LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

The new Cochlear™ Nucleus® Nexa® System is the first and only hearing implant featuring internal memory and upgradeable firmware. Approximately 63 million people in India suffer from significant ...

Cochlear™ is proud to announce FDA approval for the Cochlear Nucleus® Hybrid Implant System. The system is a groundbreaking advancement that will change the way hearing loss is treated in the United ...

LONE TREE, Colo., Jan. 11, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...

Individuals with UHL/SSD can now seek treatment with a cochlear implant from Cochlear to hear with both ears. Cochlear Limited obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...

“We are pleased to introduce SmartSound iQ and 2.4 GHz wireless connectivity to the Nucleus 6 Sound Processor as they help provide a better user experience,” said Chris Smith, President of Cochlear ...

Engaging the brain’s plasticity by stimulating the locus coeruleus, a region in the brainstem, could be a clinically relevant approach to optimize the efficacy of cochlear implants in restoring ...